Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > how do the few longs feel about jd leaving you?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(57)
•••
Comment by Comonreally42on Nov 01, 2022 3:11pm
148 Views
Post# 35064083

RE:RE:RE:RE:RE:RE:RE:how do the few longs feel about jd leaving you?

RE:RE:RE:RE:RE:RE:RE:how do the few longs feel about jd leaving you?OK see if this jogs your memory....
  • you used to say this was a 10x bagger 12 years ago
  • You were a paid pen for the company and were never objective
  • I used to laugh at you when you couldnt even write and enforce an employemnt contract because you wrote for them for 18 months sending them invoices and never got paid, you couldnt do anything about it due to your negligence
  • As a 60 something, you put all your money in a penny stock, lost it all , complained about how didnt have enough money except for food stamps ( that they dont have in Quenel) and how it deomostartes how much you dont know about investements
  • You dont have a science degree and BS for a living
  • You have promised to leave 5 times and keep coming back because no one loooks at JDSTOX
  • managment has dumped you hard and you did a 180 on everything BTI after you never got paid


I can keep going, ring a bell yet?

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities